查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613235

客自訂抗體市場：按類型、按服務、按來源、按研究領域、按最終用戶、按應用 - 2025-2030 年全球預測

Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

客自訂抗體市場2023年估值為7.5586億美元，預計到2024年將達到8.7188億美元，複合年成長率為16.10%，到2030年將達到21.499億美元。

自訂抗體市場的定義是開發和銷售針對特定抗原或表位客製化的抗體，用於研究、診斷和治療的多種應用。對客自訂抗體的需求源於其提供目標蛋白質特異性和檢測靈敏度的能力，這在免疫學、腫瘤學和神經生物學等領域非常重要。研究應用包括 ELISA、西方印漬術、免疫組織化學和流式細胞技術，並用於製藥公司、學術研究機構和診斷實驗室等最終使用領域。推動市場開拓的主要因素是慢性病盛行率的上升、研發投入的增加以及生物技術公司與研究機構之間合作的加強。該市場的最新機會包括噬菌體展示和次世代定序，這些技術提高了快速開發高親和性抗體的能力。市場相關人員可以透過建立策略聯盟並專注於拓展新興市場來抓住這些機會。然而，市場面臨著阻礙成長的挑戰，例如高昂的初始生產成本和嚴格的監管要求。此外，競爭激烈，需要不斷創新。儘管存在這些挑戰，多特異性抗體藥物複合體的開發創新提供了利潤豐厚的機會。將研究擴展到雙特異性抗體和奈米抗體等領域可以提供重要的成長途徑。考慮到市場競爭格局，重點是開發強大的抗體發現平台，競爭非常激烈。市場的本質是研究集中和動態的，不斷的進步既帶來了機遇，也帶來了挑戰。因此，鼓勵公司投資先進的研究技術並保持敏捷的營運，以適應新的市場需求並利用尖端科學進步實現永續成長。

主要市場統計
基準年[2023] 75586萬美元
預計年份 [2024] 87188萬美元
預測年份 [2030] 21.499 億美元
複合年成長率（%） 16.10%

市場動態：揭示快速發展的自訂抗體市場的關鍵市場洞察

自訂抗體市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性感染疾病全球流行
    • 擴大客自訂抗體在研究、診斷和治療的應用
    • 更多採用抗體工程和個人化治療的先進技術
  • 市場限制因素
    • 開發客自訂抗體需要花費大量的時間和精力。
  • 市場機會
    • 政府和私營部門對生命科學和臨床研究的策略性投資
    • 抗體療法的增加和藥物管道的擴展
  • 市場挑戰
    • 替代抗體的存在

波特五自訂策略工具引領客製化抗體市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解自訂抗體市場的外部影響

外部宏觀環境因素在塑造客自訂抗體市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解自訂抗體市場的競爭格局

客自訂抗體市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位自訂抗體市場供應商績效評估

FPNV定位矩陣是評估自訂抗體市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製自訂抗體市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，自訂抗體市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性感染疾病率增加
      • 擴展自訂抗體在研究、診斷和治療領域的應用
      • 更多採用抗體工程和個人化治療的先進技術
    • 抑制因素
      • 開發客自訂抗體需要大量時間和精力。
    • 機會
      • 政府和私營部門對生命科學和臨床研究進行策略性投資
      • 抗體療法的增加和藥物管道的擴展
    • 任務
      • 替代抗體的存在
  • 市場區隔分析
    • 類型：對單株抗體解決嚴重的新興需求
    • 最終用戶：製藥和生技公司增加對藥物開發和診斷的投資
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章客自訂抗體市場：依類型

  • 單株抗體
  • 多株抗體
  • 重組抗體

第7章客自訂抗體市場：依服務分類

  • 抗體開發
  • 抗體片段化和標記
  • 抗體生產和精製

第 8 章客自訂抗體市場：依來源分類

  • 老鼠
  • 兔子

第 9 章自訂抗體市場研究（按領域）

  • 心血管疾病
  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 幹細胞

第 10 章客自訂抗體市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 醫院/診所
  • 製藥和生物技術公司

第11章客自訂抗體市場：依應用分類

  • 調查
  • 治療藥物

第12章美洲客自訂抗體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區自訂抗體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東、非洲客自訂抗體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 丹納赫將以 57 億美元收購抗體供應商 Abcam
    • 默克斥資 108 億美元收購單株抗體
    • Celltrion 和 Genuve 合作開發新的治療抗體
  • 戰略分析和建議

公司名單

  • Abbiotec, Inc.
  • Abcam PLC
  • ABclonal, Inc.
  • Abgenex Pvt. Ltd.
  • Abnova Corporation
  • Acrobiosystems Inc.
  • Agilent Technologies, Inc.
  • Alta Bioscience Limited
  • Bio Basic Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioChain Incorporated
  • Bioklone Biotech Private Limited
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biosynth Ltd.
  • Boster Biological Technology
  • BTL Biotechno Labs Private Limited
  • Capralogics, Inc.
  • Cell Signaling Technology, Inc.
  • CiteAb Limited
  • Creative Biolabs
  • Creative Diagnostics
  • CSBio（Shanghai）Ltd.
  • Cusabio Technology LLC
  • Davids Biotechnologie GmbH
  • Elabscience
  • evitria AG by Atlas Antibiodies
  • GenScript Biotech Corporation
  • Imgenex India Pvt. Ltd.
  • Innovagen AB
  • Inotiv, Inc.
  • Kaneka Eurogentec SA
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Metabion International AG
  • MyBiosource, Inc.
  • OriGene Technologies, Inc.
  • Oy Medix Biochemica AB
  • Pacific Immunology
  • PhosphoSolutions
  • ProMab Biotechnologies, Inc.
  • ProSci Incorporated
  • ProteoGenix SA
  • RayBiotech Life, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • The Antibody Company
  • Thermo Fisher Scientific, Inc.
  • YenZym Antibodies, LLC
Product Code: MRR-46132FF79A8E

The Custom Antibody Market was valued at USD 755.86 million in 2023, expected to reach USD 871.88 million in 2024, and is projected to grow at a CAGR of 16.10%, to USD 2,149.90 million by 2030.

The custom antibody market is defined by the development and sale of antibodies tailored to specific antigens or epitopes for a diverse range of applications in research, diagnostics, and therapeutics. The necessity for custom antibodies stems from their ability to provide specificity and sensitivity in detecting target proteins, which is crucial in fields such as immunology, oncology, and neurobiology. Applications include use in ELISA, western blotting, immunohistochemistry, and flow cytometry, serving end-use sectors like pharmaceutical companies, academic research institutions, and diagnostic labs. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investment in research and development, and the growing number of collaborations between biotech firms and research institutes. The latest opportunities in this market include the advancement of antibody discovery technologies such as phage display and next-generation sequencing which enhance the ability to develop high-affinity antibodies swiftly. Market players are encouraged to form strategic alliances and focus on expansion into emerging markets to seize these opportunities. However, the market faces challenges including high initial production costs and stringent regulatory requirements which can hinder growth. Additionally, there is intense competition which necessitates continuous innovation. Despite these challenges, innovation in the development of multi-specific and antibody-drug conjugates presents lucrative opportunities. Expanding research into areas such as bispecific antibodies and nanobodies can offer significant growth avenues. Insight into the market indicates a highly competitive landscape with a strong focus on developing robust antibody discovery platforms. The market's nature is research-intensive and dynamic, with continuous advancements offering both opportunities and challenges. As such, businesses are recommended to invest in advanced research technologies and maintain agile operations to adapt to new market demands and leverage cutting-edge scientific advancements for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 755.86 million
Estimated Year [2024] USD 871.88 million
Forecast Year [2030] USD 2,149.90 million
CAGR (%) 16.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Custom Antibody Market

The Custom Antibody Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic infectious disease worldwide
    • Expanding applications of custom antibody across research, diagnostics, and therapeutics
    • Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
  • Market Restraints
    • Extensive and time consuming to develop custom antibodies
  • Market Opportunities
    • Governments and private sector strategically investments in life science and clinical research
    • Increase in therapeutics of antibodies and expansion of drug pipeline
  • Market Challenges
    • Presence of alternative antibodies

Porter's Five Forces: A Strategic Tool for Navigating the Custom Antibody Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Custom Antibody Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Custom Antibody Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Custom Antibody Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Custom Antibody Market

A detailed market share analysis in the Custom Antibody Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Custom Antibody Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Custom Antibody Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Custom Antibody Market

A strategic analysis of the Custom Antibody Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG by Atlas Antibiodies, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

Market Segmentation & Coverage

This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies.
  • Based on Service, market is studied across Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification.
  • Based on Source, market is studied across Mice and Rabbit.
  • Based on Research Area, market is studied across Cardiovascular Diseases, Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem cells.
  • Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Application, market is studied across Research and Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic infectious disease worldwide
      • 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
      • 5.1.1.3. Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Extensive and time consuming to develop custom antibodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Governments and private sector strategically investments in life science and clinical research
      • 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging need for monoclonal antibodies to tackle severe disease states
    • 5.2.2. End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Custom Antibody Market, by Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

  • 7.1. Introduction
  • 7.2. Antibody Development
  • 7.3. Antibody Fragmentation & Labeling
  • 7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

  • 8.1. Introduction
  • 8.2. Mice
  • 8.3. Rabbit

9. Custom Antibody Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Immunology
  • 9.4. Infectious Diseases
  • 9.5. Neurobiology
  • 9.6. Oncology
  • 9.7. Stem cells

10. Custom Antibody Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

  • 11.1. Introduction
  • 11.2. Research
  • 11.3. Therapeutics

12. Americas Custom Antibody Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Custom Antibody Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion
    • 15.3.2. Merck to Develop mAb Through USD 10.8 Billion Acquisition
    • 15.3.3. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbiotec, Inc.
  • 2. Abcam PLC
  • 3. ABclonal, Inc.
  • 4. Abgenex Pvt. Ltd.
  • 5. Abnova Corporation
  • 6. Acrobiosystems Inc.
  • 7. Agilent Technologies, Inc.
  • 8. Alta Bioscience Limited
  • 9. Bio Basic Inc.
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Bio-Techne Corporation
  • 12. BioChain Incorporated
  • 13. Bioklone Biotech Private Limited
  • 14. BioLegend, Inc. by PerkinElmer, Inc.
  • 15. Biosynth Ltd.
  • 16. Boster Biological Technology
  • 17. BTL Biotechno Labs Private Limited
  • 18. Capralogics, Inc.
  • 19. Cell Signaling Technology, Inc.
  • 20. CiteAb Limited
  • 21. Creative Biolabs
  • 22. Creative Diagnostics
  • 23. CSBio (Shanghai) Ltd.
  • 24. Cusabio Technology LLC
  • 25. Davids Biotechnologie GmbH
  • 26. Elabscience
  • 27. evitria AG by Atlas Antibiodies
  • 28. GenScript Biotech Corporation
  • 29. Imgenex India Pvt. Ltd.
  • 30. Innovagen AB
  • 31. Inotiv, Inc.
  • 32. Kaneka Eurogentec S.A.
  • 33. Laboratory Corporation of America Holdings
  • 34. Merck KGaA
  • 35. Metabion International AG
  • 36. MyBiosource, Inc.
  • 37. OriGene Technologies, Inc.
  • 38. Oy Medix Biochemica AB
  • 39. Pacific Immunology
  • 40. PhosphoSolutions
  • 41. ProMab Biotechnologies, Inc.
  • 42. ProSci Incorporated
  • 43. ProteoGenix SA
  • 44. RayBiotech Life, Inc.
  • 45. Rockland Immunochemicals, Inc.
  • 46. Sino Biological, Inc.
  • 47. The Antibody Company
  • 48. Thermo Fisher Scientific, Inc.
  • 49. YenZym Antibodies, LLC

LIST OF FIGURES

  • FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
  • FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CUSTOM ANTIBODY MARKET DYNAMICS
  • TABLE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023